122 related articles for article (PubMed ID: 7188643)
1. Norepinephrine and gamma-aminobutyric acid in amyotrophic lateral sclerosis.
Ziegler MG; Brooks BR; Lake CR; Wood JH; Enna SJ
Neurology; 1980 Jan; 30(1):98-101. PubMed ID: 7188643
[TBL] [Abstract][Full Text] [Related]
2. Relationship between cerebrospinal fluid norepinephrine and blood pressure in neurologic patients.
Ziegler MG; Lake CR; Wood JH; Brooks BR
Clin Exp Hypertens (1978); 1980; 2(6):995-1008. PubMed ID: 7449584
[TBL] [Abstract][Full Text] [Related]
3. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.
Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C
Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056
[TBL] [Abstract][Full Text] [Related]
4. [Leukotrienes and neurological diseases].
Irkeç C; Ercan S; Irkeç M
Mikrobiyol Bul; 1989 Oct; 23(4):342-7. PubMed ID: 2488942
[TBL] [Abstract][Full Text] [Related]
5. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
[TBL] [Abstract][Full Text] [Related]
6. Amyotrophic lateral sclerosis: interleukin-6 levels in cerebrospinal fluid.
Krieger C; Perry TL; Ziltener HJ
Can J Neurol Sci; 1992 Aug; 19(3):357-9. PubMed ID: 1393846
[TBL] [Abstract][Full Text] [Related]
7. [Significance of plasma creatine and neurologic disorders for the creatine level of cerebrospinal fluid in man].
Berlet HH; Pilz H
Z Neurol; 1972; 201(4):310-25. PubMed ID: 4113366
[No Abstract] [Full Text] [Related]
8. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
9. Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia.
Mishra PS; Vijayalakshmi K; Nalini A; Sathyaprabha TN; Kramer BW; Alladi PA; Raju TR
J Neuroinflammation; 2017 Dec; 14(1):251. PubMed ID: 29246232
[TBL] [Abstract][Full Text] [Related]
10. Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood-cerebrospinal fluid barrier for norepinephrine.
Ziegler MG; Lake CR; Wood JH; Brooks BR; Ebert MH
J Neurochem; 1977 Mar; 28(3):677-9. PubMed ID: 404398
[No Abstract] [Full Text] [Related]
11. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.
Smith RG; Henry YK; Mattson MP; Appel SH
Ann Neurol; 1998 Oct; 44(4):696-9. PubMed ID: 9778272
[TBL] [Abstract][Full Text] [Related]
12. Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Corbo M; Lunetta C; Magni P; Dozio E; Ruscica M; Adobbati L; Silani V
Eur J Neurol; 2010 Mar; 17(3):398-404. PubMed ID: 19845745
[TBL] [Abstract][Full Text] [Related]
13. Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis.
Johansson A; Larsson A; Nygren I; Blennow K; Askmark H
Neuroreport; 2003 Oct; 14(14):1867-9. PubMed ID: 14534437
[TBL] [Abstract][Full Text] [Related]
14. Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosis.
Parry GJ; Rodrigues CM; Aranha MM; Hilbert SJ; Davey C; Kelkar P; Low WC; Steer CJ
Clin Neuropharmacol; 2010; 33(1):17-21. PubMed ID: 19935406
[TBL] [Abstract][Full Text] [Related]
15. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.
Kuroda H; Ogawa N; Yamawaki Y; Nukina I; Ofuji T; Yamamoto M; Otsuki S
J Neurol Neurosurg Psychiatry; 1982 Mar; 45(3):257-60. PubMed ID: 7086447
[TBL] [Abstract][Full Text] [Related]
17. Free amino acid pattern of cerebrospinal fluid in amyotrophic lateral sclerosis.
Meier DH; Schott KJ
Acta Neurol Scand; 1988 Jan; 77(1):50-3. PubMed ID: 3128052
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Zheng Y; Gao L; Wang D; Zang D
Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Dobosz B
Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor is not altered in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z
Neurol Sci; 2002 Mar; 22(6):473-4. PubMed ID: 11976981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
